Interleukin 2 News and Research

RSS
Recent therapeutic strategies for renal cell carcinoma and the effects of the tumor microenvironment on systemic therapy

Recent therapeutic strategies for renal cell carcinoma and the effects of the tumor microenvironment on systemic therapy

Does the immunization order of vaccine types influence the efficacy of heterologous prime-boost vaccination, especially mRNA and protein-based vaccines?

Does the immunization order of vaccine types influence the efficacy of heterologous prime-boost vaccination, especially mRNA and protein-based vaccines?

Using synthetic gene cir­cuits to better control the timing of immunotherapy

Using synthetic gene cir­cuits to better control the timing of immunotherapy

Booster COVID-19 mRNA vaccinations marginally increase the durability of neutralizing antibody responses

Booster COVID-19 mRNA vaccinations marginally increase the durability of neutralizing antibody responses

Memory B and T cells responses differ when induced by SARS-CoV-2 infections or booster vaccinations

Memory B and T cells responses differ when induced by SARS-CoV-2 infections or booster vaccinations

Booster vaccinations in the elderly lead to impaired neutralization of SARS-CoV-2 and atypical B cells

Booster vaccinations in the elderly lead to impaired neutralization of SARS-CoV-2 and atypical B cells

Tumor-infiltrating lymphocytes therapy treats cancers at a large scale

Tumor-infiltrating lymphocytes therapy treats cancers at a large scale

What is the association between T lymphocyte-mediated immune responses and COVID-19 severity?

What is the association between T lymphocyte-mediated immune responses and COVID-19 severity?

“Drug factory” implants show promise in eradicating mesothelioma tumors

“Drug factory” implants show promise in eradicating mesothelioma tumors

B-cell responses to COVID mRNA vaccine are enhanced by a 16-week interval between doses

B-cell responses to COVID mRNA vaccine are enhanced by a 16-week interval between doses

A combined influenza and COVID-19 mRNA vaccine

A combined influenza and COVID-19 mRNA vaccine

Researchers compare the development and persistence of antibody and T-cell responses elicited by the mRNA BNT162b2 vaccine or SARS-CoV-2 infection

Researchers compare the development and persistence of antibody and T-cell responses elicited by the mRNA BNT162b2 vaccine or SARS-CoV-2 infection

New test can tell if you are immune to SARS-CoV-2

New test can tell if you are immune to SARS-CoV-2

Synthetic IL-9 receptor allows T cells to fight cancer without the need for chemo or radiation

Synthetic IL-9 receptor allows T cells to fight cancer without the need for chemo or radiation

Trial of peptide-centered SARS-CoV-2 T-cell activator in B-cell deficient individuals

Trial of peptide-centered SARS-CoV-2 T-cell activator in B-cell deficient individuals

SARS-CoV-2 Omicron found to be more immune evasive than other variants among mild COVID-19 convalescent patients

SARS-CoV-2 Omicron found to be more immune evasive than other variants among mild COVID-19 convalescent patients

Study explores polyfunctionality of BNT162b2 COVID-19 vaccine-induced memory T-cells

Study explores polyfunctionality of BNT162b2 COVID-19 vaccine-induced memory T-cells

Superior T-cell immunity in COVID vaccinated

Superior T-cell immunity in COVID vaccinated

Shared gene expression signatures in type 1 diabetics treated with IL-2 and COVID-19 patients

Shared gene expression signatures in type 1 diabetics treated with IL-2 and COVID-19 patients

Durability and functionality of the humoral and T-cell response to SARS-CoV-2 and its variants in recovered patients

Durability and functionality of the humoral and T-cell response to SARS-CoV-2 and its variants in recovered patients